<DOC>
	<DOCNO>NCT01797809</DOCNO>
	<brief_summary>The objective PMS gain information safety efficacy real practice regulatory commitment require KFDA ( Korea Food drug administration )</brief_summary>
	<brief_title>Qlaira rPMS ( Regulatory Post Marketing Surveillance ) Study Korea</brief_title>
	<detailed_description />
	<criteria>Signed date informed consent Women menarche menopause Women request contraception Women diagnose physician HMB due nonorganic cause also request contraception Women prescribe QlairaÂ® first time , study period All contraindication accord local marketing authorization consider .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>